1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
(
- Contribution to journal › Article
- 2012
-
Mark
NADiA prosvue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy
(
- Contribution to journal › Article
- 2011
-
Mark
TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
(
- Contribution to journal › Article
- 2009
-
Mark
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer : Concordance with CellSearch assay and association with bone metastases and with survival
(
- Contribution to journal › Article
- 2007
-
Mark
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Differential exoprotease activities confer tumor-specific serum peptidome patterns
(
- Contribution to journal › Article